Patrik Brundin
Affiliations: | Lund University, Lund, Skåne län, Sweden |
Area:
NeurobiologyGoogle:
"Patrik Brundin"Mean distance: 15.02 (cluster 32)
Children
Sign in to add trainee| Asa Petersen | grad student | Lund University | |
| Eva Grasbon Frodl | grad student | 1992-1996 | Munich University (LMU) |
| Naoyuki Nakao | grad student | 1993-1996 | Wakayama Medical University |
| Wei-Ming Duan | grad student | 1992-1997 | Lund University |
| Gabriele Kaminski Schierle | grad student | 1996-2000 | Cambridige University |
| Mia Emgård | grad student | 1996-2001 | Lund University |
| Jenny Karlsson | grad student | 1996-2001 | Lund University |
| Ana Sofia Correira | grad student | 2002-2006 | Lund University |
| Jorien M.M. van der Burg | grad student | 2006-2010 | Lund University |
| Elodie Angot | post-doc | 2008- | Karolinska |
| Laurent Roybon | post-doc | 2006-2008 | Lund University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hiller BM, Marmion DJ, Thompson CA, et al. (2022) Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease. Npj Regenerative Medicine. 7: 24 |
| Sargent D, Cunningham LA, Dues DJ, et al. (2021) Neuronal deletion induces spinal cord motor neuron degeneration and early post-natal lethality. Brain Communications. 3: fcab208 |
| Barbuti PA, Barker RA, Brundin P, et al. (2021) Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Hiller BM, Marmion DJ, Gross RM, et al. (2020) Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo. Stem Cells Translational Medicine |
| Espay AJ, Kalia LV, Gan-Or Z, et al. (2020) Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology |
| von Linstow CU, DeLano-Taylor M, Kordower JH, et al. (2020) Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease? Journal of Parkinson's Disease |
| Steiner JA, Quansah E, Brundin P. (2018) The concept of alpha-synuclein as a prion-like protein: ten years after. Cell and Tissue Research |
| Li W, Englund E, Widner H, et al. (2016) Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proceedings of the National Academy of Sciences of the United States of America |
| Barker RA, Parmar M, Kirkeby A, et al. (2016) Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016? Journal of Parkinson's Disease |
| Roybon L, Mastracci TL, Li J, et al. (2015) The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1. Plos One. 10: e0128035 |